Previous close | 336.35 |
Open | N/A |
Bid | 437.60 |
Ask | 445.25 |
Strike | 300.00 |
Expiry date | 2024-09-20 |
Day's range | 336.35 - 336.35 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co (NYSE:LLY) Mounjaro as initial supply shortages ease, a move driven by growing competition among retailers. The reduced prices at retailers like Simple Online Pharmacy, Mayfair Weight Loss Clinic, and London Slimming Clinic reflect the increasing demand for these weight-loss drugs. Simple Online Pharmacy, for instance, slashed the price of Mounjaro starter doses fro
Earnings season continues to chug along, with results from many companies already delivered. And concerning positivity, all three of these companies' report fit the criteria, lifting outlooks following the results.